Nektar Therapeutics NKTR
$30.20 −$2.34 (-7.19%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $30.20 0.00%
Open$31.66
Prev close$32.54
Day range$30.13 – $32.35
Volume1.02M
Market cap$1.03B
P/E (TTM)–
Dividend yield–
NKTR Stock News
Headlines matching Nektar Therapeutics or the NKTR ticker, most recent first.
- BTIG Maintains Nektar Therapeutics(NKTR.US) With Buy Rating, Maintains Target Price $178
- CCORF Maintains Nektar Therapeutics(NKTR.US) With Buy Rating, Maintains Target Price $153
- Nektar Therapeutics | SCHEDULE 13G/A: Others
- Nektar Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director GREER R SCOTT
- Nektar Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director WHITFIELD ROY A
- Piper Sandler Maintains Nektar Therapeutics(NKTR.US) With Buy Rating, Maintains Target Price $192
- A Quick Look at Today's Ratings for Nektar Therapeutics(NKTR.US), With a Forecast Between $80 to $192
- CCORF Initiates Nektar Therapeutics(NKTR.US) With Buy Rating, Announces Target Price $153
- Piper Sandler Maintains Nektar Therapeutics(NKTR.US) With Buy Rating, Raises Target Price to $192 Positive
- TD Cowen Maintains Nektar Therapeutics(NKTR.US) With Buy Rating
- Oppenheimer Maintains Nektar Therapeutics(NKTR.US) With Buy Rating, Raises Target Price to $140 Positive
- Citi Maintains Nektar Therapeutics(NKTR.US) With Buy Rating, Maintains Target Price $123
- H.C. Wainwright Maintains Nektar Therapeutics(NKTR.US) With Buy Rating, Cuts Target Price to $135 Negative
- Citi Maintains Nektar Therapeutics(NKTR.US) With Buy Rating, Raises Target Price to $151 Positive
- A Quick Look at Today's Ratings for Nektar Therapeutics(NKTR.US), With a Forecast Between $134 to $185
No comments yet — be the first to weigh in on NKTR.
Sign in to join the discussion.